https://doi.org/10.1016/s1473-3099(25)00118-5
F
Fuad Mirzayev
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
3.0K
Citations
19
h-index
24
i10-index
Fuad Mirzayev is an academic researcher from World Health Organization - Pakistan. The author has contributed to research in topics: Tuberculosis Research and Epidemiology & Pneumocystis jirovecii pneumonia detection and treatment & Pneumonia and Respiratory Infections. The author has an h-index of 19, co-authored 39 publications.
ORCID: 0000-0001-6658-0325Papers by this author
worksThe WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
2025 · The Lancet Infectious Diseases · 355 citations
Multidrug-resistant tuberculosis
2024 · Nature Reviews Disease Primers · 166 citations
https://doi.org/10.1038/s41572-024-00504-2
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis
2023 · Clinical Infectious Diseases · 32 citations
https://doi.org/10.1093/cid/ciad653
Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis
2024 · The Lancet Global Health · 11 citations
https://doi.org/10.1016/s2214-109x(24)00088-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat